EVALUATION OF THE PROTECTIVITY OF ASSESSMENT FACTORS IN THE REACH REGULATION
No Thumbnail Available
Date
2025-06-25
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Under REACH, a chemical risk assessmentis often conducted tduring the registration if
an industrial chemical. In that chemical risk assessment, assessment factors can be used
to extrapolate the toxicity of a chemical with a low amount of testing. These assessment
factors are responsible to account for four kinds of uncertainty. These uncertainties are
laboratory variation, biological variation, acute to chronic extrapolation and lab to field
extrapolation. In this thesis, these uncertainties were evaluated based on how they present
in databases from ECHA, EFSA and the US EPA. All tests with environmentally relevant
effects, commonly used test durations and with algae, crustaceans, fish and molluscs were
included in the evaluation. Additionally, the toxicity of industrial chemicals was compared
to the toxicity of pharmaceuticals and pesticides. Finally, the tiered system as proposed by
the guidance document of ECHA for REACH is evaluated on its ability to account for those
uncertainties in the first four tiers. The analysis shows that the biggest uncertainty was
the biological variation between species. The median variation between the most sensitive
and least sensitive organisms of the same species group was 100. The median acute to
chronic ratio was determined as 3.5 for algae and 11 for crustaceans, fish and molluscs. The
laboratory variation showed a median variation of 2.2 and the lab to field extrapolation
showed a median variation of 1. The median toxicity of Industrial chemicals was lower than
that of pesticides and pharmaceuticals. Industrial chemicals, which were also pesticides or
pharmaceuticals, show a higher toxicity than chemicals only classified as industrial chemicals.
Evaluating the tiered approach with the available data, the first four tiers are more protective
than the species sensitivity distribution approach in 22% of the cases.